NeoRad(Low): A phase 2 trial of neoadjuvant (NA) ipilimumab + nivolumab (ipi+nivo) with low dose stereotactic body radiation therapy (SBRT) as an immune stimulant in patients with resectable stage ...
AstraZeneca and Roche Diagnostics Asia Pacific today announced a three-year Memorandum of Understanding to help advance ...
Effects of immediate elevation of inflammatory cytokines after platinum, pemetrexed, and pembrolizumab on antitumor efficacy in advanced non-squamous, non-small cell lung cancer. Unraveling relatlimab ...
Oncology experts from all over the world will discuss the latest developments in care. ASCO bills its 2026 meeting as “the ...
Lung adenocarcinoma is the most common type of lung cancer diagnosed in the U.S. Just over half of all non-small-cell lung cancers (NSCLCs) are adenocarcinomas. Finding out that you're at risk of lung ...
"We found a significant association of genetically estimated sensitivity to environmental stress and adversity in relation to lung cancer risk among individuals of European ancestry, as well as in a ...
For nearly half of people diagnosed with lung cancer, immunotherapy can slow the disease but not stop it. Funded through a $4 million joint investment from the Canadian Cancer Society (CCS) and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results